Related Experiment Video
Updated: Mar 28, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
H274Y's Effect on Oseltamivir Resistance: What Happens Before the Drug Enters the Binding Site
Muhammad Yusuf1, Nornisah Mohamed1, Suriyati Mohamad1,2
1Pharmaceutical Design and Simulation (PhDS) Laboratory, School of Pharmaceutical Sciences, Universiti Sains Malaysia , 11800 Minden, Pulau Pinang, Malaysia.
Abstract:
Increased reports of oseltamivir (OTV)-resistant strains of the influenza virus, such as the H274Y mutation on its neuraminidase (NA), have created some cause for concern. Many studies have been conducted in the attempt to uncover the mechanism of OTV resistance in H274Y NA. However, most of the reported studies on H274Y focused only on the drug-bound system, so the direct effects of the mutation on NA itself prior to drug binding still remain unclear. Therefore, molecular dynamics simulations of NA in apo form, followed by principal component analysis and interaction energy calculations, were performed to investigate the structural changes of the NA binding site as a result of the H274Y mutation. It was observed that the disruption of the NA binding site due to the H274Y mutation was initiated by the repulsive effect of Y274 on the 250-loop, which in turn altered the hydrogen-bonding network around residue 274. The rotated W295 side chain caused the upward movement of the 340-loop. Consequently, sliding box docking results suggested that the binding pathway of OTV was compromised because of the disruption of this binding site. This study also highlighted the importance of the functional group at C6 of the sialic acid mimicry. It is hoped that these results will improve the understanding of OTV resistance and shed some light on the design of a novel anti-influenza drug.
Insights
Oseltamivir resistance in influenza emerges from the H274Y mutation in neuraminidase (NA). This mutation disrupts the NA binding site, compromising drug efficacy and impacting anti-influenza drug design.
Area of Science:
- Virology
- Structural Biology
- Drug Discovery
Background:
- Oseltamivir (OTV) resistance in influenza viruses is a growing concern, particularly strains with the H274Y mutation in neuraminidase (NA).
- Previous studies on H274Y resistance primarily focused on drug-bound states, leaving the mutation's intrinsic effects on NA structure unclear.
Purpose of the Study:
- To investigate the direct structural impact of the H274Y mutation on the NA binding site in the absence of the drug.
- To elucidate the mechanism by which the H274Y mutation affects OTV binding and resistance.
Main Methods:
- Molecular dynamics simulations of NA in apo form.
- Principal component analysis (PCA) and interaction energy calculations.
- Sliding box docking simulations.
Main Results:
- The H274Y mutation disrupts the NA binding site, initiated by a repulsive effect on the 250-loop and altered hydrogen bonding.
- The mutation causes conformational changes, including the rotation of W295 and upward movement of the 340-loop.
- These structural changes compromise the binding pathway for OTV, suggesting reduced drug efficacy.
Conclusions:
- The H274Y mutation intrinsically alters NA structure, leading to OTV resistance.
- Understanding these structural changes is crucial for designing next-generation anti-influenza drugs.
- The C6 functional group of sialic acid mimics is important for drug interaction.
More Related Videos
Related Concept Videos
Influenza
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Leaky Scanning
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...

